Egyptian International Pharmaceutical Industries Company's latest marketcap:
As of 07/05/2025, Egyptian International Pharmaceutical Industries Company's market capitalization has reached $149.35 M. According to our data, Egyptian International Pharmaceutical Industries Company is the 22021th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 149.35 M |
| Revenue (ttm) | 165.73 M |
| Net Income (ttm) | 16.02 M |
| Shares Out | 148.76 M |
| EPS (ttm) | 0.11 |
| Forward PE | 6.97 |
| Ex-Dividend Date | 04/22/2025 |
| Earnings Date | 08/13/2025 |
Egyptian International Pharmaceutical Industries Company's yearly market capitalization.
| Date | Market Cap(EGP) | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | 149.35 M | 10.67% | 22021 |
| 12/31/2024 | 6.83 B | 25.78% | 21579 |
| 12/31/2023 | 5.43 B | 49.96% | 19695 |
| 12/29/2022 | 3.62 B | -12.86% | 19976 |
| 12/30/2021 | 4.16 B | -3.57% | 17241 |
| 12/31/2020 | 4.31 B | -34.63% | 15095 |
| 12/31/2019 | 6.59 B | -22.13% | 11082 |
| 12/31/2018 | 8.46 B | -30.29% | 9442 |
| 12/31/2017 | 12.14 B | 74.86% | 8973 |
| 12/29/2016 | 6.94 B | 22.45% | 10452 |
Company Profile
About Egyptian International Pharmaceutical Industries Company
Egyptian International Pharmaceutical Industries Company (EIPICO) is a leading pharmaceutical manufacturer specializing in the production of pharmaceutical ampoules. Established in 1980 and headquartered in 10th of Ramadan City, Egypt, the company serves both domestic and international markets.
Product Portfolio
EIPICO offers a diverse range of pharmaceutical products, including:
- Analgesics & Antipyretics – Pain and fever relief medications
- Anti-Infectives – Treatments for bacterial and viral infections
- Cardiovascular & Metabolic – Solutions for heart and metabolic disorders
- Corticosteroids – Anti-inflammatory and immune-modulating drugs
- Gastrointestinal Tract – Digestive health medications
- Nervous System – Neurological and psychiatric treatments
- Ophthalmic – Eye care solutions
- Respiratory – Treatments for asthma and respiratory conditions
- Topical Ointments & Creams – Dermatological products
- Vitamins – Nutritional supplements
- Miscellaneous – Additional specialized medications
Global Reach
In addition to serving the Egyptian market, EIPICO exports its high-quality pharmaceutical products to international markets, reinforcing its reputation as a trusted healthcare provider.
Frequently Asked Questions
-
What is Egyptian International Pharmaceutical Industries Company's (EGX-PHAR) current market cap?As of 07/05/2025, Egyptian International Pharmaceutical Industries Company (including the parent company, if applicable) has an estimated market capitalization of $149.35 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Egyptian International Pharmaceutical Industries Company (EGX-PHAR) rank globally by market cap?Egyptian International Pharmaceutical Industries Company global market capitalization ranking is approximately 22021 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.